AI assistant
Sending…
Theravance Biopharma, Inc. — Director's Dealing 2017
Nov 22, 2017
32537_dirs_2017-11-22_160032e8-e06d-4793-bca1-6a348a12fc45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Theravance Biopharma, Inc. (TBPH)
CIK: 0001583107
Period of Report: 2017-11-20
Reporting Person: WORBOYS PHILIP D (SVP, Translational Science)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-20 | Ordinary Shares | F | 5503 | $28.58 | Disposed | 159129 | Direct |
More from Theravance Biopharma, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25